- Home
- ACHV vs MGYR Comparison
ACHV vs MGYR Comparison
Compare ACHV & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- MGYR
- Stock Information
- Founded
- ACHV N/A
- MGYR 1922
- Country
- ACHV Canada
- MGYR United States
- Employees
- ACHV N/A
- MGYR N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MGYR Savings Institutions
- Sector
- ACHV Health Care
- MGYR Finance
- Exchange
- ACHV Nasdaq
- MGYR Nasdaq
- Market Cap
- ACHV 92.6M
- MGYR 94.1M
- IPO Year
- ACHV N/A
- MGYR 2006
- Fundamental
- Price
- ACHV $2.51
- MGYR $13.86
- Analyst Decision
- ACHV Strong Buy
- MGYR
- Analyst Count
- ACHV 4
- MGYR 0
- Target Price
- ACHV $15.75
- MGYR N/A
- AVG Volume (30 Days)
- ACHV 157.9K
- MGYR 3.2K
- Earning Date
- ACHV 05-08-2025
- MGYR 04-22-2025
- Dividend Yield
- ACHV N/A
- MGYR 1.80%
- EPS Growth
- ACHV N/A
- MGYR 10.61
- EPS
- ACHV N/A
- MGYR 1.30
- Revenue
- ACHV N/A
- MGYR $32,424,000.00
- Revenue This Year
- ACHV N/A
- MGYR N/A
- Revenue Next Year
- ACHV N/A
- MGYR N/A
- P/E Ratio
- ACHV N/A
- MGYR $10.66
- Revenue Growth
- ACHV N/A
- MGYR 7.24
- 52 Week Low
- ACHV $2.48
- MGYR $10.66
- 52 Week High
- ACHV $5.59
- MGYR $14.90
- Technical
- Relative Strength Index (RSI)
- ACHV 35.98
- MGYR 37.73
- Support Level
- ACHV $2.70
- MGYR $13.85
- Resistance Level
- ACHV $2.99
- MGYR $14.09
- Average True Range (ATR)
- ACHV 0.19
- MGYR 0.19
- MACD
- ACHV -0.01
- MGYR -0.05
- Stochastic Oscillator
- ACHV 5.17
- MGYR 1.20
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.